Nirvan Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 1996.
1996 Delhi, Delhi, India Active
Last Updated:
Access Report
About Nirvan Pharmaceuticals Private Limited

Nirvan Pharmaceuticals Private Limited, a active private limited company, was established on 07 March 1996 in Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U33112DL1996PTC076859. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹8.00 M.

It upholds a compliant status. Its leadership includes Dharmvir Rao Singh (Director), Sunil Yadav (Director), Siddhasvir Nirvan (Director). Past directors included Indrakaran Reddy Allola, Harish Kumar Kondapally, Amar Deep Singh. It holds ₹70.26 Cr open charges and ₹41.49 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at H - 4/9, Model Town,, Delhi, Delhi, 110009.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33112DL1996PTC076859

  • Registration Number

    076859

  • Incorporation Date

    07 March 1996

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹8.00 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 8.00 M
  • Company Age 29 Year, 11 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 70.26 Cr
  • Satisfied Charges ₹ 41.49 Cr
  • Revenue Growth **** 3.48%
  • Profit Growth **** 43.40%
  • Ebitda **** 71.40%
  • Net Worth -112.33%
  • Total Assets **** 37.83%
Company report

Nirvan Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nirvan Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Nirvan Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Dharmvir Rao Singh Director 26 Aug 1996 Current
Sunil Yadav Director 06 Nov 2006 Current
Siddhasvir Nirvan Director 03 Jun 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 29 Sep 2020 Past
Pramod Abcsdd Additional Director 29 Sep 2023 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Director - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nirvan Pharmaceuticals.

Nirvan Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.48% increase. The company also saw a substantial improvement in profitability, with a 43.4% increase in profit. The company's net worth observed a substantial decline by a decrease of 112.33%.

Nirvan Pharmaceuticals revenue growth over time
Nirvan Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 3.48%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 37.83%
*******
*******
*******
*******
Profit or Loss
*******
 43.40%
*******
*******
*******
*******
Net Worth
*******
 -112.33%
*******
*******
*******
*******
EBITDA
*******
 71.40%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nirvan Pharmaceuticals?

In 2023, Nirvan Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹702,600,000.00

Satisfied Charges

₹414,900,000.00

Charges Breakdown by Lending Institutions
  • Bajaj Finance Limited : 28.00 Cr
  • State Bank Of India : 20.05 Cr
  • Others : 19.36 Cr
  • Punjab & Sind Bank : 2.85 Cr
Latest Charge Details
Date Lender Amount Status
09 Feb 2018 Others ₹19.36 Cr Open
02 Jul 2015 Bajaj Finance Limited ₹10.00 Cr Open
31 Dec 2014 Bajaj Finance Limited ₹18.00 Cr Open
12 Jul 2007 State Bank Of India ₹7.35 Cr Open
14 May 2007 State Bank Of India ₹12.70 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Nirvan Pharmaceuticals?

Unlock and access historical data on people associated with Nirvan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nirvan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nirvan Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nirvan Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Siddhasvir Nirvan was appointed as a Director was appointed as a Director on 03 Jun 2025 & has been associated with this company since 8 months 10 days . was documented.

  • Annual General Meeting

    Nirvan Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Nirvan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi. was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 19.36 Cr with Charge ID 100162822 was registered on 09 Feb 2018. was recorded as a recent event.

  • Charges

    Progress on A charge with Bajaj Finance Limited amounted to Rs. 10.00 Cr with Charge ID 10577832 was registered on 02 Jul 2015. was documented.

  • Charges

    A charge registered on 01 Jun 2013 via Charge ID 10432815 with Indiabulls Housing Finance Limited was fully satisfied on 21 Apr 2015. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nirvan Pharmaceuticals Private Limited?

The CIN of Nirvan Pharmaceuticals Private Limited is U33112DL1996PTC076859.

Where is Nirvan Pharmaceuticals Private Limited headquartered?

Nirvan Pharmaceuticals Private Limited is headquartered at H - 4/9, Model Town,, Delhi, Delhi, 110009.

When was Nirvan Pharmaceuticals Private Limited incorporated?

Nirvan Pharmaceuticals Private Limited was incorporated on 07 March 1996.

Who are the current directors of Nirvan Pharmaceuticals Private Limited?

The current directors of Nirvan Pharmaceuticals Private Limited are

What is the primary industry of Nirvan Pharmaceuticals Private Limited?

The primary industry of Nirvan Pharmaceuticals Private Limited is Pharma.

Is Nirvan Pharmaceuticals Private Limited a listed company?

Nirvan Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Nirvan Pharmaceuticals Private Limited?

The authorized capital of Nirvan Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹8.00 M.

What is the compliance status of Nirvan Pharmaceuticals Private Limited?

The compliance status of Nirvan Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available